Article Text

See original article:

Download PDFPDF
Human transforming growth factor α (TGF-α) is digested to a smaller (1–43), less biologically active, form in acidic gastric juice
  1. T Marchbank1,
  2. R Boulton2,
  3. H Hansen3,
  4. R J Playford1
  1. 1Imperial College Faculty of Medicine, Department of Gastroenterology, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK
  2. 2Department of Gastroenterology, Middlesex Hospital, Sterling Way, Edmonton, London N18 1QX, UK
  3. 3Imperial Cancer Research Fund, Lincolns Inn Fields, London W2C 2PX, UK
  1. Correspondence to:
    Professor R J Playford, Gastroenterology Section, Imperial College School of Medicine, Hammersmith Hospital Campus, Du Cane Rd, London W12 0NN, UK;
    r.playford{at}ic.ac.uk

Abstract

Background: Transforming growth factor α (TGF-α) is a 50 amino acid peptide with potent proliferative and cytoprotective activity present in gastric mucosa and juice.

Aims: To determine the forms and biological activity of natural and recombinant TGF-α following incubation with acid pepsin.

Patients: Human gastric juice was obtained under basal conditions from patients taking acid suppressants and from volunteers undergoing intragastric neutralisation.

Methods: Samples were analysed using mass spectroscopy and/or high pressure liquid chromatography with radioimmunoassay. Biological activity was determined using thymidine incorporation into rat hepatocytes and an indomethacin/restraint induced gastric damage rat model.

Results: TGF-α1–50 is cleaved to TGF-α1–43 by acid pepsin and this is the predominant form in normal gastric juice. However, intragastric neutralisation or taking acid suppressants caused the predominant form to be TGF-α1–50. TGF-α1–43 had only half of the ability to maximally stimulate [3H]thymidine incorporation into primary rat hepatocytes (28 177 (1130) DPM/well for 2.16 nM TGF-α1–43v 63 184 (3536) DPM/well for TGF-α1–50; p<0.001). A similar reduced potency was seen when used in an indomethacin induced rat gastric damage model (0.18 μmol/kg/h of TGF-α1–43 reduced ulcer area by 19% whereas TGF-α1–50 reduced area by 62%; p<0.001).

Conclusions: TGF-α1–50 is cleaved to the TGF-α1–43 form by acid pepsin, causing 2–5-fold loss of biological activity. Such changes may have relevance to the actions of acid suppressants and the importance of this peptide in both normal and abnormal growth.

  • transforming growth factor
  • gastric juice
  • HPLC, high pressure liquid chromatography
  • AcN, acetonitrile
  • TFA, trifluoroacetic acid
  • EGF, epidermal growth factor
  • EGF-R, epidermal growth factor receptor
  • PPI, proton pump inhibitor
  • RIA, radioimmunoassay
  • TGF-α, transforming growth factor α

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

Linked Articles

  • CORRECTION
    C L Ch'ng J G C Kingham M Morgan I Hainsworth